ASCO GI: Bone Drugs Cut CRC Risk
SAN FRANCISCO (MedPage Today) — Postmenopausal women taking oral bisphosphonates for osteoporosis had almost a 50% reduction in the risk of colorectal cancer, according to a large cohort study.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com